Clinical Trials Logo

Hyperandrogenism clinical trials

View clinical trials related to Hyperandrogenism.

Filter by:

NCT ID: NCT03905603 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

SHK001
Start date: October 8, 2019
Phase: Early Phase 1
Study type: Interventional

The objective of the study is to determine the relative contributions of four established predictors of hyperandrogenism (luteinizing hormone [LH] secretion, ovarian response to recombinant human chorionic gonadotropin [r-hCG] administration, adrenal response to adrenocorticotropic hormone [ACTH] administration, and hyperinsulinemia) in older vs. young women with Polycystic Ovary Syndrome (PCOS) in a cross-sectional, physiological study. The investigators hypothesize that hyperinsulinemia is a stronger independent predictor of free testosterone (T) in older reproductive aged (vs. young) women with PCOS.

NCT ID: NCT03864068 Recruiting - Insulin Resistance Clinical Trials

Inositol Supplementation to Treat PCOS (INSUPP-PCOS)

INSUPP-PCOS
Start date: January 24, 2020
Phase: Phase 2
Study type: Interventional

To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).

NCT ID: NCT03757923 Recruiting - Hyperandrogenism Clinical Trials

Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism

mprmih
Start date: June 18, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

To compare metformin with pioglitazone in improving menstrual irregularities and hyperandrogenism in women with PCOS so that an alternate and better treatment option will be available for hyperinsulinemia in pcos patients.

NCT ID: NCT03742011 Recruiting - Insulin Resistance Clinical Trials

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

PCOS-BIG
Start date: February 1, 2012
Phase:
Study type: Observational

The Offspring Born to Mothers with Polycystic Ovary Syndrome in Guangzhou Cohort study (PCOS-BIG) was established to investigate the short- and long-term effects of intrauterine exposure to maternal PCOS on the health of offspring in Guangzhou, China. Data are collected regarding maternal PCOS subtypes, nursing, diet and education as well as health outcomes in their later life. Biological samples including blood and tissue samples are also collected from participants.

NCT ID: NCT03068910 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

CRM008
Start date: July 21, 2016
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to determine if, in mid- to late pubertal girls with hyperandrogenism, androgen-receptor blockade (spironolactone) improves the ability of progesterone to acutely reduce waking luteinizing hormone pulse frequency (primary endpoint).

NCT ID: NCT02647827 Recruiting - Insulin Resistance Clinical Trials

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

PIAII
Start date: December 2015
Phase: Phase 2
Study type: Interventional

The hypothesis is that acupuncture is equally effective as metformin (both treatments combined with lifestyle management) in improving whole body glucose homeostasis in insulin resistant women with polycystic ovary syndrome (PCOS), and that both are superior to lifestyle management alone. The investigators hypothesize that acupuncture and metformin induce ovulation and improve hyperandrogenism, as well as health related quality of life (HRQoL) and symptoms of anxiety and depression. Although equally effective (acupuncture and metformin), the investigators hypothesize that acupuncture is associated with less negative side-effects. The investigators also hypothesize that these treatments have the potential to restore epigenetic and molecular alterations in target tissues (endometrial-, adipose-, and skeletal muscle tissue) and thus have the potential to prevent the development of type 2 diabetes (T2D).

NCT ID: NCT02155933 Recruiting - Hyperandrogenism Clinical Trials

Assessment of Day-night Secretion of Progesterone and LH Across Puberty

LH
Start date: July 10, 2008
Phase:
Study type: Observational

Hormones are substances that are made by the body and are sent directly out into the bloodstream to increase or decrease the function of certain organs, glands, or other hormones. Testosterone is a hormone found in the blood of all girls, but some girls have too much testosterone in their blood. Too much testosterone in the blood can possibly lead to a problem called polycystic ovary syndrome (PCOS). People with PCOS have abnormal menstrual periods, excess facial and body hair, and too much testosterone in their blood. On the other hand, some girls with too much testosterone in their blood do not develop PCOS. We do not know why some of these girls develop PCOS and why some do not. The purpose of this research study is to find out whether too much testosterone can cause problems with other hormones that can lead to the development of PCOS. This study may help us understand more about the causes of PCOS.

NCT ID: NCT02027337 Recruiting - Clinical trials for Polycystic Ovarian Syndrome

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Start date: December 2013
Phase: Phase 4
Study type: Interventional

We investigate parameters of hemocoagulation and lipoperoxidation in women using combined oral contraceptives with antiandrogenic activity (containing drospirenone with 20 or 30 mcg ethinylestradiol; or cyproterone acetate); correction of these changes by antioxidants

NCT ID: NCT01711476 Recruiting - Clinical trials for Polycystic Ovary Syndrome (PCOS) Women

Meal Timing on Glucose and Hyperandrogenism in PCOS Women

MealTimePCOS
Start date: October 2012
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the effects of two isocaloric maintenance diets with different meal timing distribution on insulin resistance hyperandrogenism and cytochrome P450c17 alpha activity in lean PCOS women. The investigators hypothesis is that in lean PCOS women a Breakfast Diet (BD) which consist in high calorie breakfast and reduced dinner, vs Dinner Diet (DD) which consist in high calorie dinner with reduced breakfast; the BD will improve glucose and insulin response to OGTT and would decrease the hyperandrogenism and cytochrome P450c17 alpha activity.

NCT ID: NCT01428089 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

Start date: March 11, 2011
Phase: Phase 1
Study type: Interventional

During childhood, the levels of certain hormones: gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen, and progesterone are very low. However, when puberty starts, GnRH and LH pulses begin to increase, but they initially do so at night only. It is unknown why GnRH and LH pulses increase at night and then decrease during the day (instead of being increased all the time). The purpose of this study is to see how quickly progesterone reduces LH pulses. The study is also meant to find out whether too much testosterone (also a hormone) in the blood causes problems with the ability of progesterone to reduce LH pulses. In this study, the investigators aim to discover whether or not giving 3 small doses of progesterone to pubertal girls will prevent the nighttime increase of LH pulses. From the information gathered in this study, the investigators may be able to learn more about how menstrual cycles are normally established in girls during puberty. Ultimately, if the investigators understand these normal processes, the investigators may be able to better understand abnormalities of puberty.